| abstract |
Recognition of a target oligosaccharide molecule by a polycationic small molecule inhibitor and treatment of immune diseases and infectious diseases. By using a polycationic low molecular weight substance and binding to an oligosaccharide biomolecule, the action in vivo is regulated or inhibited. Compounds that inhibit nitric oxide, TNFα, or other immunostimulatory agents and that are useful in the treatment of immune diseases and infections are provided. [Selection figure] None |